Phase II study of conformal hypofractionated radiotherapy with concurrent gemcitabine in muscle-invasive bladder cancer. by Choudhury, A, Swindell, R, Logue, J, Elliott, P, Livsey, J, Wise, M, Symonds, P, Wylie, J, Ramani, V, Sangar, V, Lyons, J, Bottomley, I, McCaul, D, Clarke, N, Kiltie, A, Cowan, R